More than 13,000 bottles of a blood pressure medication recalled
The recall involves Chlorthalidone Tablets, USP, 25 mg, a medication used to treat high blood pressure and certain types of fluid retention.
FDA logo in Los Angeles, California / Patrick T. Fallon
More than 13,000 bottles of a prescription medication used to treat high blood pressure are being recalled because the tablets did not dissolve properly, according to information from the Food and Drug Administration (FDA).
The recall affects Chlorthalidone Tablets, USP, 25 mg, a medication used to treat high blood pressure and certain types of fluid retention.
The pharmaceutical company Inventia Healthcare Limited, based in India, voluntarily initiated the recall on September 3. Subsequently, the FDA classified it as a Class II recall on September 17.
According to the FDA, a Class II recall means that use of the product could cause temporary or medically reversible health problems, although the likelihood of serious consequences is considered remote.
Health
Strep cases rise as students return to school: What symptoms to watch out for
Diane Hernández
In total, the recall involves 13,567 bottles of chlorthalidone. Each bottle contains 100 25-mg tablets.
The affected products are from lot RISA24002, have an expiration date of April 2027, and bear the NDC number 64980-599-01.
The FDA stated that the drug was recalled because the tablets did not dissolve properly.
The FDA notified customers
According to the FDA's database, the company notified customers via letter. The agency also notes that the manufacturer did not issue a public announcement regarding the recall.
To date, the FDA has not recorded any injuries or illnesses related to the product in its recall notice.
LATEST
